The combination of Regemat 3D bioprinting technologies, which allow printing structures that mimic human living tissues, combined with technologies from the Bmap line of bioreactors, which allow tissue functionalization reproducing the anatomical and physiological characteristics enhancing mechanobiology to its maximum expression, it is resulting in fully functional human tissues that could even be implanted.
This combination of technologies applied in the fields of tissue engineering, regenerative medicine and the development of new biomaterials is leading to the achievement of incredible results in research areas such as:
The biggest problem faced by companies in the pharmaceutical industry is dealing with the high costs of the patient trial phases, which begin without total guarantees of success.
When a target molecule that could be a future new drug is detected, in vitro tests are started, then it is passed to the animal model and if the results are successful ultimately it is passed to the human model. But the results obtained in the animal model are not always reproduced in the human model, it also happens in reverse way since sometimes molecules that give positive results in the animal model but that perhaps could have it in patients are discarded.
Thanks to the use of Regemat 3D technologies, this GAP is being covered between the animal model and the human model, since researchers can, for example, print colon cancer tumors to test the molecules directly on them, thus obtaining results that more closely match those obtained in the patient trial.
Additionally, other applications of Regemat 3D technologies in the pharmaceutical industry are for example:
The Regemat 3D equipment, thanks to its versatility in terms of the possibility of applications, its intuitive and easy-to-use software and its affordable price, undoubtedly make our technology the best option for educational purposes.
Our team of engineers and the after-sales service, always at the disposal of our collaborators to solve doubts and queries at the level of protocols and printing processes is a very important tool for the optimal management and control of equipment for users who start in the world of 3D bioprinting.
The company’s systems are present today in many training centers that offer degrees or postgraduate degrees in bioengineering, biomedical engineering, tissue engineering, biology, medicine or pharmacy. The mission of Regemat 3D is also closely linked to the education and training of new researchers and that is why we participate as part of the teaching staff in various expert and master courses in centers of worldwide renown.
The purpose of applying 3D bioprinting and bioreaction technologies at the research level is undoubtedly to reach the clinical application of the results obtained.
The main objective of Regemat 3D is to reach the clinical stage, which is why we not only accompany and support our collaborators during the entire research process but also act as a link with those groups that can transfer to the clinic the research results. We also help our collaborators to obtain funding for their research and actively participate in dozens of national and international projects.
In fact, at Regemat 3D we are starting our own clinical trials in countries such as Spain and Mexico focused on the regeneration of osteochondral lesions and with the aim of providing a real solution to pathologies such as osteoarthritis or knee arthritis.
If you are interested into 3D bioprinting, have doubts about your bioprinter or even if you want to know more about biomaterials or the needed configuration for your research, please don´t hesitate to contact us sending an email to info@regemat3d.com or by writing a message below. Our team Will be contacting you in short.